PROTOCOL NIDA-CTN-0051-A-2


Treatment-As-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with CTN-0051

This ancillary study is related to CTN-0051, "Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)."

This is an observational study intended to describe opioid use amongst opioid use disorder patients following their discharge into the community from inpatient detoxification and/or short-term residential treatment programs affiliated with CTN-0051. The primary outcome is to estimate treatment-as-usual rates of opioid use clinical outcomes following discharge to the community in this convenience sample.

RELATED STUDIES

 

RELATED RESOURCES

snowflake

ClinicalTrials.gov (NCT02730403)


NODES & CTPs SEARCH LINK
Greater New York (Lead) search www
  Bellevue Hospital Center search www
Florida Node Alliance search www
Gateway Community Services search www
New England Consortium search www
SSTAR of Massachusetts search www
Ohio Valley search www
Maryhaven, Inc. search www
Pacific Region search www
Tarzana Treatment Center search www

Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 11/2016 -- http://ctndisseminationlibrary.org/protocols/ctn0051a2.htm
info@ctndisseminationlibrary.org